Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.40 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.37 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.37 |
| ▸ | KDR | P35968 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23488447 | 1.00 | XDH (0.44) | XDHTDP1PTPN1ERBB2EPHA2 | |
| SCHEMBL23488678 | 0.86 | TDP1 (0.47) | XDHTDP1PTPN1 | |
| SCHEMBL23488568 | 0.86 | TDP1 (0.47) | XDHTDP1PTPN1 | |
| SCHEMBL23488542 | 0.84 | LGALS3 (0.38) | PTPN1EPHX2 | |
| SCHEMBL23488709 | 0.84 | LGALS8 (0.44) | PTPN1 | |
| SCHEMBL23488601 | 0.83 | TDP1 (0.44) | XDHTDP1PTPN1ERBB2EPHA2 | |
| SCHEMBL23488536 | 0.83 | TDP1 (0.44) | XDHTDP1PTPN1ERBB2EPHA2 | |
| SCHEMBL23488654 | 0.81 | CA2 (0.45) | — | |
| SCHEMBL23488695 | 0.80 | TDP1 (0.43) | XDHTDP1ERBB2EPHA2KDR | |
| SCHEMBL23488299 | 0.80 | TDP1 (0.44) | XDHTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210170033-A1 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | SANOFI (FR) | 2021-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210170033-A1 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | GPR119, SLC2A8, SLC2A4 | XDH 3028/4885TDP1 4093/4885PTPN1 2662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.